SPDR S&P Pharmaceuticals ETF
XPH
XPH
79 hedge funds and large institutions have $112M invested in SPDR S&P Pharmaceuticals ETF in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 25
Holders
79
Holding in Top 10
–
Calls
$344K
Puts
–
Top Buyers
| 1 | +$5.2M | |
| 2 | +$5.2M | |
| 3 | +$2.22M | |
| 4 |
FCM
Fortis Capital Management
Bellevue,
Washington
|
+$2.07M |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
+$1.24M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$10.6M | |
| 3 | -$3.45M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.66M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.76M |